TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 47 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,074 | -38.8% | 258,844 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $75,324 | -84.6% | 258,844 | 0.0% | 0.00% | -80.0% |
| Q1 2023 | $489,215 | +26.8% | 258,844 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $385,678 | -10.7% | 258,844 | 0.0% | 0.01% | -18.2% |
| Q3 2022 | $432,000 | -19.6% | 258,844 | -3.5% | 0.01% | -21.4% |
| Q2 2022 | $537,000 | -23.9% | 268,301 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $706,000 | -5.0% | 268,301 | 0.0% | 0.02% | -5.9% |
| Q4 2021 | $743,000 | -28.4% | 268,301 | 0.0% | 0.02% | -41.4% |
| Q3 2021 | $1,038,000 | -45.6% | 268,301 | -8.8% | 0.03% | -52.5% |
| Q2 2021 | $1,908,000 | -21.2% | 294,031 | 0.0% | 0.06% | -33.0% |
| Q1 2021 | $2,420,000 | -29.7% | 294,031 | 0.0% | 0.09% | -28.9% |
| Q4 2020 | $3,440,000 | +181.5% | 294,031 | +24.4% | 0.13% | +73.0% |
| Q3 2020 | $1,222,000 | – | 236,301 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $9,746,000 | 1.82% |
| Altium Capital Management LP | 785,341 | $3,039,000 | 0.80% |
| Ikarian Capital, LLC | 2,691,110 | $10,415,000 | 0.73% |
| Telemetry Investments, L.L.C. | 130,500 | $505,000 | 0.68% |
| Psagot Value Holdings Ltd. | 143,591 | $556,000 | 0.10% |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556,000 | 0.10% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $110,000 | 0.06% |
| X-Square Capital, LLC | 17,973 | $70,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 85,993 | $333,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $1,038,000 | 0.03% |